Nanoparticles: A personal experience for formulating poorly water soluble drugs

Journal of Controlled Release

Volumn 141, Issue 3, 2010, Pages 300-302

  Cooper, Eugene R ^a  

^a NONE   (United States)

Author keywords

Enhanced bioavailability; Nanosizing; Particle size reduction; Poorly soluble drugs

Indexed keywords

NANOMETER SIZE RANGE; NANOSIZING; PARTICLE SIZE REDUCTION; PERSONAL EXPERIENCE; POORLY SOLUBLE DRUGS; POORLY WATER-SOLUBLE DRUGS;

BIOCHEMISTRY; DRUG DELIVERY; NANOPARTICLES; SIZE DETERMINATION;

MICROCRYSTALS;

NANOPARTICLE; PACLITAXEL;

DISPERSION; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG SOLUBILITY; HUMAN; MAXIMUM TOLERATED DOSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; SCALE UP; SURFACE TENSION;

DRUG COMPOUNDING; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; WATER;

EID: 75549088273     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.10.006     Document Type: Review

References (2)

1. Merisko-Liversidge E., Liversidge G.G., Cooper E.R. Nanosizing: a formulation approach for poorly soluble compounds. Eur. J. Pharm. Sci. 2003, 18:113-120.
2. Elan's NanoCrystal Technology is protected by many US and foreign patents and patent applications.